Aim: To investigate effects of icariin on cardiac gene expression and the modulation of nitric oxide (NO) signal transduction during the differentiation of embryonic stem (ES) cells into cardiomyocytes in vitro. Methods: The expression levels of cardiac developmental-dependent genes were measured using reverse transcription-polymerase chain reaction (RT-PCR). The chronotropic responses of cardiomyocytes to β-adrenoceptor stimulation were determined. The levels of cAMP and cGMP in ES cells were measured using radioimmunoassay. Endogenous NO levels were measured by using the Griess reaction. Aminoguanidine (AG) was used to confirm the influence of icariin on the endogenous NO signal pathway. Results: Icariin significantly elevated mRNA levels of cardiac transcription factors GATA4 and Nkx2.5, and cardiac-specific α-MHC, MLC-2v and β-AR genes in a concentration-and time-dependent manner (P<0.05). Cardiomyocytes derived from embryoid body (EB) treated with icariin were more sensitive to isoprenaline (P<0.01). Treatment of ES cells with icariin resulted in a continued elevation in the cAMP/cGMP ratio before a shift to the cardiomyocyte phenotype (P<0.05). AG decreased the NO level, and delayed and decreased the incidence of contracting EB to only approximately 35% on d 5+11, an effect that could be rescued by icariin. When cells were cocultured with icariin and AG, the percentage of beating EB reached a peak level of 73% on d 5+11 (P<0.05). Conclusion: The inducible effects of icariin were partly related to increase in the expression of cardiac developmental-dependent genes, and elevation of the cAMP/cGMP ratio in ES cells, as well as upregulation of endogenous NO generation during the early stages of cardiac development.
Introduction
Herba Epimedii is an important traditional Chinese herbal medicine that is widely used as a tonic, aphrodisiac, and antirheumatic in China. The content of icariin, its effective ingredient, has been used as a quality control standard. In our previous work, the specific properties of embryonic stem (ES) cells and standard culture methods [1] were used to confirm the inducible effects of icariin and its two metabolites on the differentiation of ES cells into cardiomyocytes in vitro [2] . Icariin at a concentration of 1×10 -7 mol/L facilitates the directional differentiation of ES cells into cardiomyocytes. Cardiomyocytes are characterized by the expression of sarcomeric proteins, α-actinin and cardiac troponin T. Icariin has been found to have effects on regulation of the cell cycle, induction of apoptosis, as well as modulation of p53 during the early differentiation of ES cells and cardiac development, by using flow cytometry, reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis [3] . But the other possible mechanisms by which icariin inducibly affects the directional differentiation of ES cells into cardiomyocytes are still not completely understood and it is worthwhile to investigate them further.
Cardiac-specific genes, proteins, receptors and signaling molecules are expressed in a developmentally controlled manner during cardiac differentiation of ES cells in vitro, which closely recapitulate the developmental pattern of early cardiogenesis in vivo [4] . With a view to detecting the targets of icariin action during the promotion of ES cells to differentiate, the expression of cardiac developmentaldependent genes was measured using RT-PCR, and the chronotropic responses of cardiomyocytes to β-adrenoceptor stimulation were determined.
The second messengers, cAMP and cGMP, play an important part in regulating cellular proliferation and differentiation. It is crucial that the correct cAMP/cGMP ratio is maintained. Moreover, if a compound heightens the cAMP level of cells, it may facilitate differentiation and inhibit proliferation [5, 6] . Therefore, the levels of cAMP and cGMP in ES cells treated with icariin were measured to clarify the possible actions of icariin on early differentiation events before a shift to the cardiomyocyte phenotype.
NO, a potential differentiation signal molecule, is important for cardiac development. It has been reported that incubation of embryoid body (EB) with nitric oxide synthase (NOS) inhibitors resulted in a pronounced differentiation arrest of cardiomyocytes, whereas this effect could be reversed by coapplication of the NO donor. In the development of cardiogenesis, the classic mode of action of NO is through intracellular signaling cascades via the activation of cGMP [7] . When administered orally, icariin can increase the mRNA and protein expression of eNOS and iNOS as a result of regulating the endogenous NO level to enhance erectile function [8] . In the present study, we tested the hypothesis that icariin promoted the differentiation of ES cells into cardiomyocytes in part through regulating the endogenous NO signaling pathway. The concentration of endogenous NO in ES cells during differentiation was evaluated by using the Griess reaction. In addition, aminoguanidine (AG), an effective and selective inhibitor of iNOS, was used to explore the influence of icariin on endogenous NO levels in the differentiation of ES cells into cardiomyocytes, and to confirm the targets of icariin action.
Materials and methods

Cells, drugs, and reagents
The permanent ES cell line D3 (ES-D3) was obtained from the American Type Culture Collection (CRL-1934). Icariin was obtained from the Drug Biology Product Examination Bureau, Beijing, China (batch No 0737-200011, purity 99%); retinoic acid (RA), β-mercaptoethanol, aminoguanidine (AG) and monoclonal anti-sarcomeric-actinin were purchased from Sigma (St Louis, MO, USA); Dulbecco's modified Eagle's minimal essential medium (DMEM) was purchased from Gibco Invitrogen Corporation (Grand Island, NY, USA). Fetal calf serum (FCS) and the non-essential amino acids (NEAA) were purchased from Hyclone (Logan, UT, USA). Mitomycin C was purchased from Kyowa Hakko Kogyo (Tokyo, Japan); and recombinant mouse leukemia inhibitory factor (LIF) was purchased from Chemicon International (Temecula, CA, USA). The fluorescein isothiocyanate (FITC)-conjugated F(ab) 2 [2, 9, 10] with differentiation medium. On d 5, EBs were plated separately onto gelatin-coated 24-well culture plates, and at that time, icariin was added to the medium at concentrations of 1×10 -7 , 1×10 -8 , or 1×10 -9 mol/L, on the basis of preliminary test results. EBs treated with 1×10 -8 mol/L RA or with 0.1% dimethyl sulfoxide (Me 2 SO) solvent were used as positive or negative controls, respectively. To explore whether icariin promoted the differentiation of ES cells into cardiomyocytes in part through regulating the endogenous NO signaling pathway, AG at a concentration of 1×10 -3 mol/L was added to differentiation medium together with icariin on d 5 and maintained until d 5+11 (ie, 11 d after EB was plated onto gelatin-coated culture plates on d 5). EB was observed with a light microscope every day to record the number of spontaneously beating EB.
In the experiment, d 1 corresponds to the day of dissociation of ES cells from MEF cells, and the initiation of differentiation by the formation of EB. To identify whether the observed cell types derived from ES-D3 cells were cardiomyocytes, indirect immunofluorescence for cardiac-specific protein was carried out according to a method published elsewhere [2, 3] . Detection of cardiac-specific transcripts by semi-quantitative RT-PCR analysis Total RNA was isolated from EBs (n=20) induced by 1×10 -7 , 1×10 -8 or 1×10 -9 mol/L icariin, 1×10 -8 mol/L RA or solvent at different time points by using Trizol reagent. After extraction, mRNA was precipitated and dissolved in a 0.1% diethylpyrocarbonate solution. To synthesize first strand cDNA, 7 µL total RNA was incubated in 0.5 µg of oligo (dT) 6 o C. The PCR products were separated by 1.5% agarose gel electrophoresis, visualized with ethidium bromide staining, and quantified using a Bio-imaging Analyzer (Bio-Rad,CA,USA), and the density of the products were quantitated using Quantity One (version 4.2.2) software (Bio-Rad).
Measurement of contraction of cardiomyocytes derived from ES-D3 cells
The in vitro function of ES-D3 cell-derived cardiomyocytes was examined by evaluating the chronotropic effects of cardio-active drugs [12] . Isoprenaline (a β-AR agonist) was cumulatively added to the pulsating clusters of EB induced by 1×10 -7 mol/L icariin, 1×10 -8 mol/L RA or solvent on d 5+5, d 5+9, and d 5+13, respectively. Then the frequencies were measured in control (ie, the basal level of beating frequency, before agonist treatment) and agonisttreated variants to create dose-response curves. Measurements were also carried out in the presence of the antagonist propranolol. Images of the beating cardiomyocytes were monitored with a charge coupled device (CCD) video camera attached to the microscope observation port, and also displayed on a computer screen. The frequency of contraction was detected by using a photoelectricity transformation system, which transformed photic signals into electrical signals [13] . cAMP and cGMP determination assay To clarify the mechanism by which icariin affects the early differentiation of ES cells before a shift to the cardiomyocyte phenotype, cAMP and cGMP levels in ES cells were measured by using a 125 I-cAMP and 125 I-cGMP double antibody radioimmunoassay method [14] . ES-D3 cells were cultivated without MEF feeders and LIF, and treated with 1×10 -7 mol/L icariin or 1×10 -8 mol/L RA. After 24-48 h, the cells were harvested, placed into a polypropylene tube and centrifuged. The supernatant was removed and 1 mL acetic acid buffer (pH 4.5) at 4 o C was added to the cell pellet. Then samples were repeatedly frozen in liquid nitrogen and quickly melted in warm water (5 times). Protein was removed by centrifugation at 5000×g for 30 min.
Measurement of supernatant NO production Supernatant NO concentration was measured by using the Griess reaction [14] . The nitrite concentration was determined by using a curve calibrated with a sodium nitrite standard.
Statistical analysis Data were expressed as Mean±SD. At least 3 independent experiments were carried out to cal- [11] F CTGCTGGAGAGGTTATTCCTCG 30 1 R GGAAGAGTGAGCGGCGCATCAAGG MLC-2v [11] F TGTGGGTCACCTGAGGCTGTGGTTCAG 18 9 R GAAGGCTGACTATGTCCGGGAGATGC β-AR
-6 mol/L caused a reduction in the frequency increase. A representative trace showing the effect of isoprenaline and propranolol on the beat frequency of the cardiomyocytes is shown in Figure 4 .
Levels of cAMP and cGMP in ES cells
The concentrations of cAMP and cGMP in ES cells were 0.233 nmol/L and 0.060 nmol/L, respectively, and the cAMP/cGMP ratio was 3.875. When ES cells were treated with icariin at a concentraculate mean. Statistical significance was evaluated with oneway ANOVA by using SPSS 10.0 for Windows. P<0.05 was considered statistically significant.
Results
Identification of cardiomyocytes derived from ES-D3 cells
Apparent cell morphological changes during the course of differentiation were shown in Figure 1 . The differentiated beating cardiac cells stained positively with anti-α-actinin mAb. These results accorded with those of our previous studies [2, 3] . Expression of cardiac-specific genes during the early cardiac developmental stage Cardiomyocytes from EB expressed the cardiac transcription factors GATA4 and Chronotropic responses of ES-D3 cell-derived cardiomyocytes The spontaneously beating capacity of ES cellderived cardiomyocytes enables the investigation of the chronotropic effect of cardioactive substances by measuring the beating frequency of cardiac cells [12] . A positive chronotropic response was observed after administration of the β-agonist isoprenaline. Furthermore, the effect of isoprenaline on ES-D3 cell derived cardiomyocytes was different in the early and late developmental stages. The beating EBs early on d 5+5 were insensitive to isoprenaline ( Figure  3A) . In an intermediate phase (d 5+9), the beating frequency was significantly increased in the presence of isoprenaline in a concentration-dependent manner (P<0.01). The frequency of beating EB treated with 1×10 -7 mol/L icariin was increased by 20% when 1×10 -11 mol/L isoprenaline was added. As the concentration of isoprenaline increased gradually to 1×10 -6 mol/L, the frequency was increased by approximately 80%, whereas the corresponding increase was only 50% for controls ( Figure 3B ). At the terminal differentiation stage (d 5+13), the cardiomyocytes were highly sensitive to isoprenaline (P<0.01). In the presence of isoprenaline at concentrations ranging from 1×10 -11 to 1×10 -6 mol/L, the contraction rate of cardiomyocytes induced by 1×10 -7 mol/L icariin increased from approximately 30% to 130% ( Figure  3C ). Propranolol (a β-adrenoceptor antagonist) at a concen- tion of 1×10 -7 mol/L for 24 h, the levels of cAMP and cGMP significantly increased to 0.660 nmol/L and 0.083 nmol/L, respectively (P<0.05). The cAMP/cGMP ratio also increased to 7.870. Treatment of ES cells with icariin for 48 h caused elevation of the concentration of cAMP and the ratio of cAMP/cGMP (P<0.01), but the concentration of cGMP was barely increased ( Table 2) .
Production of supernatant NO In the control, supernatant NO production was low. When ES cells were treated with icariin at a concentration of 1×10 -7 mol/L for 24 h or 48 h, supernatant NO production was markedly elevated (P<0.05). In particular, the NO-cGMP pathway was involved in the early differentiation of ES cells treated with icariin for 24 h. During the course of differentiation (from d 5+2 to d 5+11), icariin facilitated the directional differentiation of ES cells into cardiomyocytes, and supernatant NO generation increased (P<0.05). In the presence of AG, an effective and selective inhibitor of iNOS, NO generation during differentiation decreased significantly, but was rescued by icariin (P<0.05; Figures 5 and 6 ).
Inducible effect of icariin together with AG on the directional differentiation of ES-D3 cells into cardiomyocytes
To further determine the effects of icariin on modulation of the endogenous NO signaling pathway during the differentiation of ES cells into cardiomyocytes, cultures were supplemented with AG to partially block NO production. Under these conditions, whether the percentage cardiac differentiation was influenced, and the number of spontaneously beating EB were recorded. ES cells were induced into rhyth- mically beating EB by icariin in a concentration-and timedependent manner [3] . The percentage differentiation in cultures containing contracting EB with 1×10 -7 mol/L icariin was approximately 7% on d 5+3, and reached a peak level of 86% on d 5+11 (P<0.05). In the control, only approximately 55% beating EBs were found on d 5+11. AG significantly delayed and decreased the incidence of contracting EB compared with control cells: beating EB was not observed until d 5+4 and the percentage was only approximately 35% on d 5+11. When icariin-treated cells were co-cultured with AG, AG produced a decrease in the percentage of beating EB to 73% on d 5+11 compared with cells treated with icariin alone. The potential of EB to undergo cardiac differentiation was significantly enhanced in comparison with that in solvent together with AG treatment starting from d 5+3 (P<0.05; Figure 7 ). 
Discussion
Our experiments demonstrated that icariin markedly enhanced the mRNA levels of GATA4, Nkx2.5, α-MHC, MLC2v and β-AR at the early stage of differentiation. It has been reported that the GATA4 and Nkx2.5 transcription factors appear before other cardiac genes are expressed [15] . Myocardial genes such as α-MHC are expressed relatively early during the course of cardiogenesis [16] ; however, MLC-2v mRNA is expressed at high levels relatively late, and is spatially restricted to the ventricular area [17] . In the present study RT-PCR analysis revealed that cardiac differentiation of ES cells induced by icariin recapitulated this developmental pattern, as GATA4 and Nkx2.5 were detected earlier than cardiac α-MHC, MLC-2v and β-AR. Icariin-induced MLC-2v expression upregulation was detected as early as d 5+2, whereas increased expression in control cells was not observed until d 5+7. These results suggest that one of the mechanisms by which icariin is involved in differentiation is by facilitating the expression of the cardiac developmentaldependent genes in a developmentally controlled manner. In particular, icariin could enhance the development of ventricular cardiomyocytes at an early differentiation stage.
It is important to characterize the responses of cardiomyocytes derived from ES cells, and one of the key modulators of contraction is the β-AR system [18, 19] , therefore in the present study the responses of the beating rate of cardiomyocytes to β-AR stimulation were determined. We confirmed that β-AR responses were well developed in cardiomyocytes derived from ES cells. The cardiomyocytes treated with icariin were more sensitive to isoprenaline than the case of in controls. The different sensitivities of the cardiomyocytes to isoprenaline may result from the different expression levels and the degree of maturity of β-AR [20] , the hypothesis that is supported by the results of our RT-PCR analysis.
NO is a potential differentiation signal that plays an important role in the differentiation of ES cells into cardiomyocytes [21] . In most instances, NO signaling pathways are typically dependent on cGMP. The cGMP-dependent pathways are initiated by NO-induced activation of soluble guanylate cyclase by binding to heme iron. This activation results in a transient increase in the second messenger cGMP [22] . Another messenger, cAMP, also plays an important role in regulating cellular proliferation and differentiation. The effects of cAMP and cGMP are opposite. It is crucial to maintain the correct cAMP/cGMP ratio to provide the correct microenvironment for cell survival and function. Upregulation of cAMP is a key process for facilitating differentiation and inhibiting proliferation. Icariin induces the differentiation of HL-60 cells, possibly by elevating the cAMP/cGMP ratio [5] . In the present study, treatment of ES cells with icariin for 24-48 h resulted in an elevated cAMP concentration and cAMP/ cGMP ratio. This indicates that upregulation of cAMP concentration and cAMP/cGMP ratio is important for the differentiation of ES cells in early differentiation events, before a shift to the cardiomyocyte phenotype. In the present study, when ES cells were treated with icariin for 24-48 h before a shift to the cardiomyocyte phenotype, supernatant NO production was markedly elevated. The cGMP level was also elevated with icariin treatment for only 24 h. On the basis of the results of the radioimmunoassays and the Griess reaction measurements, we suggest that the NO-cGMP pathway is only involved in the early differentiation of ES cells treated with icariin for 24 h before a shift to the cardiomyocyte phenotype. However, the fact that the involvement of NO was independent of cGMP in early differentiation warrants further investigation.
Further studies were aimed at the involvement of icariin in the NO signaling pathway during cardiomyocyte phenotype formation. NO is generated by the NOS family of proteins. Both NO and NOS isoforms have been shown to induce or facilitate the differentiation of several cell types, including nerve cells [23] , some tumor cell types [24] , and cardiac cells [25] . ES cell-derived cardiomyocytes have been found to have an identical pattern of NOS expression as that detected in mouse heart. In the early developmental stage, ES cell-derived cardiomyocytes displayed strong iNOS and eNOS expression. Conversely, in the late developmental stage, iNOS was not detected and eNOS expression was found only at low levels. iNOS was expressed only in the early cardiac differentiation stage and was important for cardiac development. Work with mouse ES cells has shown that NOS inhibitors arrest differentiation toward the cardiac phenotype, and this effect can be rescued by NO donors [21] . Orally administered icariin has been shown to increase the mRNA and protein expression of eNOS and iNOS and regulate the level of NO to enhance erectile function [8] . However, whether icariin improves cardiovascular function in part through regulating the level of NO has not been demonstrated. In the present study, an in vitro model was used to investigate the influence of NOS inhibitors on cardiac development within EB treated with icariin. AG is an effective and specific inhibitor of iNOS. During the course of differentiation, icariin facilitated the directional differentiation of ES cells into cardiomyocytes and supernatant NO concentration increased. AG decreased the endogenous NO level and arrested differentiation toward the cardiac phenotype. This effect of AG could be rescued by icariin. These findings suggest that icariin promotes the differentiation of ES cells into cardiomyocytes in part through upregulating the endogenous NO level, which may be related to inducing iNOS expression. They also indicate that NO plays an important role in normal cardiac development as a potential differentiation signaling molecule.
In conclusion, the promoting effects of icariin on cardiac differentiation depended on advancing and increasing the expression of the GATA4, Nkx2.5, α-MHC, MLC-2v and β-AR genes. Icariin could also increase cAMP concentration and the cAMP/cGMP ratio, and promote endogenous NO generation during early differentiation and cardiac development.
